Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Advanced NSCLC
NCT00075426Phase 2Completed
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Nov 2002
- Primary completion
- Jul 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in non-small cell lung cancer (NSCLC), sponsored by The University of Texas Medical Branch at Galveston. Started Nov 2002; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00075426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075426.